How soon should patients with smear-positive tuberculosis be released from inpatient isolation?

Infection Control and Hospital Epidemiology

Volumn 31, Issue 1, 2010, Pages 78-84

  Horne, David J ^a,e   Johnson, Catherine O ^c   Oren, Eyal ^d   Spitters, Christopher ^b,d   Narita, Masahiro ^a,c,d  

^a Divisions of Pulmonary and Critical Care Medicine   (United States)

^b Allergy and Infectious Diseases   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HOSPITAL PATIENT; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT COUNSELING; SPUTUM CULTURE; SPUTUM SMEAR; SURVIVAL; THORAX RADIOGRAPHY;

ADULT; AGED; ANTITUBERCULAR AGENTS; BACTERIOLOGICAL TECHNIQUES; COHORT STUDIES; CULTURE MEDIA; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PATIENT ISOLATION; PREDICTIVE VALUE OF TESTS; SPECIMEN HANDLING; SPUTUM; SURVIVAL ANALYSIS; TIME FACTORS; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 72449138209     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/649022     Document Type: Article

References (20)

1. American Thoracic Society/Centers for Disease Control and Prevention/ Infectious Diseases Society of America: controlling tuberculosis in the United States. Am J Respir Crit Care Med 2005; 172:1169-1227.
2. Lienhardt C, Manneh K, Bouchier V, et al. Factors determining the outcome of treatment of adult smear-positive tuberculosis cases in the Gambia. Int J Tuberc Lung Dis 1998; 2:712-718.
3. Singla R, Osman MM, Khan N, et al. Factors predicting persistent sputum smear positivity among pulmonary tuberculosis patients 2 months after treatment. Int J Tuberc Lung Dis 2003; 7:58-64.
4. Dominguez-Castellano A, Muniain MA, Rodriguez-Bano J, et al. Factors associated with time to sputum smear conversion in active pulmonary tuberculosis. Int J Tuberc Lung Dis 2003; 7:432-438.
5. Telzak EE, Fazal BA, Pollard CL, et al. Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis. Clin Infect Dis 1997; 25:666-670.
6. Guler M, Unsal E, Dursun B, et al. Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis. Int J Clin Pract 2007; 61:231-235.
7. Rieder HL. Sputum smear conversion during directly observed treatment for tuberculosis. Tuber Lung Dis 1996; 77:124-129.
8. Fortun J, Martin-Davila P, Molina A, et al. Sputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation? J Antimicrob Chemother 2007; 59:794-798.
9. Kim TC, Blackman RS, Heatwole KM, et al. Acid-fast bacilli in sputum smears of patients with pulmonary tuberculosis: prevalence and significance of negative smears pretreatment and positive smears post-treatment. Am Rev Respir Dis 1984; 129:264-268.
10. Horne DJ, Johnson CO, Oren E, et al. Factors affecting time to sputum smear and culture conversion in patients with pulmonary tuberculosis. Am J Respir Crit Care Med 2008; 177:A790.
11. Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167:603-662.
12. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000; 161:1376-1395.
13. Report of Verified Case of Tuberculosis Manual. Available at: http://wonder.cdc.gov/wonder/help/TB/RVCTFormCompletion-Instructions.pdf. Accessed January 16, 2009.
14. Hosmer DW, Lemeshow S, May S. Applied survival analysis : regression modeling of time-to-event data. 2nd ed. Hoboken, NJ: Wiley-Interscience, 2008.
15. van Soolingen D, Borgdorff MW, de Haas PE, et al. Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997. J Infect Dis 1999; 180:726-736.
16. Mariam DH, Mengistu Y, Hoffner SE, et al. Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2004; 48:1289-1294.
17. Garcia-Garcia ML, Ponce de Leon A, Jimenez-Corona ME, et al. Clinical consequences and transmissibility of drug-resistant tuberculosis in southern Mexico. Arch Intern Med 2000; 160:630-636.
18. Al-Moamary MS, Black W, Bessuille E, et al. The significance of the persistent presence of acid-fast bacilli in sputum smears in pulmonary tuberculosis. Chest 1999; 116:726-731.
19. Iseman MD. An unholy trinity-three negative sputum smears and release from tuberculosis isolation. Clin Infect Dis 1997; 25:671-672.
20. Sepkowitz KA. Tuberculosis control in the 21st century. Emerg Infect Dis 2001; 7:259-262.